Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of an Intervention Targeting Motivational Negative Symptoms: Switch Protocol 2

NCT04325100 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT04325100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04325100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of an Intervention Targeting Motivational Negative Symptoms: Switch Protocol 2
Lead sponsor
University of Liege
Phase
Not applicable
Overall status
Completed
Start date
April 20, 2019
Completion date
February 27, 2020
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, major depressive disorder, schizo affective disorder, schizophrenia